Pancreatic Cancer Research

ResearcherTongji UniversityActive in the last 2 years

Wei Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1919-594X; OpenAlex author ID A5100344395. Sources: OpenAlex.

Their work

Papers
10 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
36
Papers, trials and grants by year

2019: 4 papers · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 2 papers · 2024: 1 paper · 2025: 1 paper

Papers 10

  1. A Phase I/II Study Protocol of a Novel Neoadjuvant 'PRaG' Regimen (Radiotherapy, GM-CSF, and Cadonilimab) with AG Chemotherapy to Improve Resectability in Loca… Co-author DOI 10.1177/15330338251399255↗
  2. Exosome-derived tRNA fragments tRF-GluCTC-0005 promotes pancreatic cancer liver metastasis by activating hepatic stellate cells. Co-author DOI 10.1038/s41419-024-06482-3↗
  3. PPDPF Promotes the Development of Mutant KRAS-Driven Pancreatic Ductal Adenocarcinoma by Regulating the GEF Activity of SOS1. Co-author DOI 10.1002/advs.202202448↗
  4. Inhibition of epithelial-to-mesenchymal transition augments antitumor efficacy of nanotherapeutics in pancreatic ductal adenocarcinoma. Co-author DOI 10.1111/febs.16879↗
  5. Elevated expression of nuclear receptor-binding SET domain 3 promotes pancreatic cancer cell growth. Co-author DOI 10.1038/s41419-021-04205-6↗
  6. Chimeric peptide supramolecular nanoparticles for plectin-1 targeted miRNA-9 delivery in pancreatic cancer. Last author DOI 10.7150/thno.38327↗
  7. miR-9-5p inhibits pancreatic cancer cell proliferation, invasion and glutamine metabolism by targeting GOT1. Last author DOI 10.1016/j.bbrc.2018.12.114↗
  8. Long non-coding RNA PXN-AS1 suppresses pancreatic cancer progression by acting as a competing endogenous RNA of miR-3064 to upregulate PIP4K2B expression. Co-author DOI 10.1186/s13046-019-1379-5↗
  9. miR-486 Promotes Capan-2 Pancreatic Cancer Cell Proliferation by Targeting Phosphatase and Tensin Homolog Deleted on Chromosome 10 (PTEN). Co-author DOI 10.3389/fgene.2019.00541↗
  10. Inflammatory and Senescent Phenotype of Pancreatic Stellate Cells Induced by Sqstm1 Downregulation Facilitates Pancreatic Cancer Progression. Last author DOI 10.7150/ijbs.27825↗

Closest collaborators

The 25 strongest of 36 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Liyuan Zhang · 1 shared paper, 2025 · strength 0.26
  2. Meiling Xu · 1 shared paper, 2025 · strength 0.26
  3. Mengdie Cao · 1 shared paper, 2024 · strength 0.19
  4. Jingwen Liang · 1 shared paper, 2024 · strength 0.19
  5. Luyao Liu · 1 shared paper, 2024 · strength 0.19
  6. Bin Cheng · 1 shared paper, 2024 · strength 0.19
  7. Yuchong Zhao · 1 shared paper, 2024 · strength 0.19
  8. Saimeng Shi · 1 shared paper, 2023 · strength 0.16
  9. Qinglin Fei · 1 shared paper, 2023 · strength 0.16
  10. Weiding Wu · 1 shared paper, 2023 · strength 0.16
  11. Zhenyu Liao · 1 shared paper, 2023 · strength 0.16
  12. Tianjiao Li · 1 shared paper, 2023 · strength 0.16
  13. Long‐Yun Ye · 1 shared paper, 2023 · strength 0.16
  14. Xianjun Yu · 1 shared paper, 2023 · strength 0.16
  15. Kaizhou Jin · 1 shared paper, 2023 · strength 0.16
  16. Bo Wang · 1 shared paper, 2019 · strength 0.14
  17. Juan Wang · 1 shared paper, 2019 · strength 0.14
  18. Zhenyu Ye · 1 shared paper, 2021 · strength 0.13
  19. Shang Cai · 1 shared paper, 2021 · strength 0.13
  20. Yecheng Li · 1 shared paper, 2021 · strength 0.13
  21. Yihui Sun · 1 shared paper, 2021 · strength 0.13
  22. Meiyi Song · 1 shared paper, 2019 · strength 0.12
  23. Lu Xia · 1 shared paper, 2019 · strength 0.12
  24. Xiaoying Zhou · 1 shared paper, 2019 · strength 0.12
  25. Han Chen · 1 shared paper, 2019 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.